Singh Divya, Cho William C, Upadhyay Ghanshyam
Department of Biology, City College of New York New York, NY, USA.
Department of Clinical Oncology, Queen Elizabeth Hospital Kowloon, Hong Kong.
Front Physiol. 2016 Jan 26;6:363. doi: 10.3389/fphys.2015.00363. eCollection 2015.
The liver is the center for drug and xenobiotic metabolism, which is influenced most with medication/xenobiotic-mediated toxic activity. Drug-induced hepatotoxicity is common and its actual frequency is hard to determine due to underreporting, difficulties in detection or diagnosis, and incomplete observation of exposure. The death rate is high, up to about 10% for drug-induced liver damage. Endorsed medications represented >50% of instances of intense liver failure in a study from the Acute Liver Failure Study Group of the patients admitted in 17 US healing facilities. Albeit different studies are accessible uncovering the mechanistic aspects of medication prompted hepatotoxicity, we are in the dilemma about the virtual story. The expanding prevalence and effectiveness of Ayurveda and natural products in the treatment of various disorders led the investigators to look into their potential in countering drug-induced liver toxicity. Several natural products have been reported to date to mitigate the drug-induced toxicity. The dietary nature and less adverse reactions of the natural products provide them an extra edge over other candidates of supplementary medication. In this paper, we have discussed the mechanism involved in drug-induced liver toxicity and the potential of herbal antioxidants as supplementary medication.
肝脏是药物和外源性物质代谢的中心,受药物/外源性物质介导的毒性活动影响最大。药物性肝毒性很常见,由于报告不足、检测或诊断困难以及对暴露情况的观察不完整,其实际发生率难以确定。死亡率很高,药物性肝损伤的死亡率高达约10%。在美国17家医疗机构收治的急性肝衰竭研究组的一项研究中,获批药物导致的严重肝衰竭病例占比超过50%。尽管有不同的研究揭示了药物性肝毒性的机制方面,但我们对实际情况仍感到困惑。阿育吠陀医学和天然产物在治疗各种疾病方面的普及率和有效性不断提高,促使研究人员探究它们在对抗药物性肝毒性方面的潜力。迄今为止,已有几种天然产物被报道可减轻药物诱导的毒性。天然产物的膳食性质和较少的不良反应使其比其他补充药物候选物更具优势。在本文中,我们讨论了药物性肝毒性的相关机制以及草药抗氧化剂作为补充药物的潜力。